• Home
  • ABResearch srl

ABResearch srl

About ABResearch srl

Founded in 2009 by professionals with a strong experience in Nutraceuticals and Nutricosmetics, ABR represents the junction between the innovation offered by biotechonology and classic production methods of actives. As matter of fact, ABR developed a proprietary industrial platform for the production of active ingredients extracted from specifc, non GMO, n...

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Certificates:
    3
  • Employees:
    25 - 49
Company types
Contract Service
Manufacturer/Innovator
Contact info
Show contact info Hide contact info

Products from ABResearch srl (3)

  • ACTEOS 10P - Lippia citriodora cell culture extract

    Product ACTEOS 10P - Lippia citriodora cell culture extract

    Lippia Citriodora cell culture extract.Verbascoside (VB), also named Acteoside, is a phenylpropanoid glycosides water-soluble classified.
    The plant extracts, titled in VB, possesses broad-spectrum anti-inflammatory, anti-hypertensive, anti-asthmatic, anti-oxidative and immunotoxin properties. ...
  • APPLIVER® CHOLESTEROL

    Product APPLIVER® CHOLESTEROL

    APPLIVER® CHOLESTEROL is the new product obtained by the ABR innovative biotechnological platform NATRISE®.
    APPLIVER® is a freeze-drying  Cydonia oblonga stem cells compound obtained by plant cell culture.
    The Cydonia oblonga is anapple-shaped fruit, with a de...
  • APPLIVER® FIBROSIS

    Product APPLIVER® FIBROSIS

    APPLIVER® is the new product obtained by the ABR innovative biotechnological platform NATRISE®.
    APPLIVER® is a freeze-drying Cydonia oblonga  fruit stem cells culture. The  Cydonia oblongais an apple-shaped fruit, with a delicious aroma and it is known for its e...

ABResearch srl Resources (2)

  • Anti-fibrotic properties of APPLIVER on in vitro models of non-alcoholic steatohepatitis

    News Anti-fibrotic properties of APPLIVER on in vitro models of non-alcoholic steatohepatitis

    In collaboration with the research groups of Fondazione Italiana Fegato Onlus (FIF)  APPLIVER™ was tested in in vitro model of non-alcoholic fatty liver disease (NAFLD), characterized to develop fibrosis.
    23 Sep 2021
  • APPLIVER FIBROSIS

    Brochure APPLIVER FIBROSIS

    APPLIVER® is the new product obtained by the ABR innovative biotechnological platform NATRISE®.
     Our research studies confirm the beneficial effect on health of APPLIVER® in metabolic disorder as NAFLD.

    This makes APPLIVER® the perfect ingredient for dietary supplements and functional foods.